Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Min Wu
Institutions:
Anhui Medical University,
Jiaxing University,
First Affiliated Hospital of Anhui Medical University,
First Affiliated Hospital of Bengbu Medical College
Observed institutions:
Anhui Medical University,
Jiaxing University,
First Affiliated Hospital of Anhui Medical University,
First Affiliated Hospital of Bengbu Medical College
ORCID:
0009-0003-2053-7948
Observed ORCID:
0009-0003-2053-7948
OpenAlex ID:
A5121793079
A dual-active biological scaffold with in situ loaded Abaloparatide and bone marrow-derived mesenchymal stem cells synergistically regulatory T cell to promote bone regeneration
2026
·
Mingyu Jia
, Zhihong Chen
, et al.
·
Biomaterials Advances
·
7
iNGR-Modified Brucine-Loaded Liposomes Enhance Tumor Penetration and Suppress Ovarian Cancer Peritoneal Metastasis
2026
·
Mei Zhao
, Weiyu Li
, et al.
·
International Journal of Nanomedicine
Corrigendum to “Transdermal delivery of brucine-encapsulated liposomes significantly enhances anti-tumor outcomes in treating triple-negative breast cancer” [Biomater. Adv. 153 (2023) 213566]
2026
·
Min Wu
, Yi Hu
, et al.
·
Biomaterials Advances
PDF
Supplementary Figure S7 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
PDF
Supplementary Figure S2 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
PDF
Supplementary Figure S5 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
Supplementary Figure S10 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
Supplementary Figure S6 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
Supplementary Figure S1 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
PDF
Supplementary Figure S11 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
PDF
Supplementary Table S1 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
Supplementary Figure S12 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
Supplementary Figure S9 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
PDF
Supplementary Figure S3 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
PDF
Data from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
Supplementary Figure S4 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
PDF
Supplementary Figure S8 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
2026
·
Huan Zhang
, Fufan He
, et al.
PDF
Show more works
View as search
Works count:
17
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type